Natural Beauty Bio-Technology Limited (HKG:0157)
Hong Kong · Delayed Price · Currency is HKD 0.4950
+0.0050 (1.02%)
Jan 20, 2026, 3:39 PM HKT
HKG:0157 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 461.41 | 353.65 | 336.02 | 335.88 | 487.81 | 410.67 | Upgrade | |
Revenue Growth (YoY) | 39.29% | 5.25% | 0.04% | -31.14% | 18.78% | -6.33% | Upgrade |
Cost of Revenue | 205.24 | 151.32 | 135.67 | 146.75 | 181.81 | 170.25 | Upgrade |
Gross Profit | 256.17 | 202.33 | 200.35 | 189.13 | 306 | 240.43 | Upgrade |
Selling, General & Admin | 257.19 | 251.39 | 208.17 | 207.82 | 265.23 | 234.06 | Upgrade |
Other Operating Expenses | 2.47 | 0.4 | -4.17 | -4.09 | -1.38 | -5.81 | Upgrade |
Operating Expenses | 259.62 | 251.66 | 199.93 | 208.45 | 259.87 | 230.3 | Upgrade |
Operating Income | -3.45 | -49.33 | 0.42 | -19.32 | 46.13 | 10.12 | Upgrade |
Interest Expense | -7.58 | -8.05 | -8.13 | -4.34 | -1.82 | -1.66 | Upgrade |
Interest & Investment Income | 1.15 | 0.85 | 1.51 | 1.65 | 2.05 | 1.74 | Upgrade |
Currency Exchange Gain (Loss) | -4.18 | - | - | 2.43 | - | -1.69 | Upgrade |
EBT Excluding Unusual Items | -14.13 | -56.53 | -6.21 | -19.58 | 46.36 | 8.51 | Upgrade |
Impairment of Goodwill | -24.81 | -24.81 | - | -2.13 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -1.26 | 0.01 | 0.1 | - | -0.2 | 0.09 | Upgrade |
Asset Writedown | -23.88 | -23.88 | -5.76 | -3.8 | 0.53 | 0.38 | Upgrade |
Other Unusual Items | - | - | - | 1.97 | 1.77 | - | Upgrade |
Pretax Income | -64.08 | -105.21 | -11.87 | -23.55 | 48.46 | 8.98 | Upgrade |
Income Tax Expense | -1.85 | -1.59 | 3.24 | 6.92 | 13.2 | 1.23 | Upgrade |
Net Income | -62.23 | -103.62 | -15.11 | -30.47 | 35.26 | 7.76 | Upgrade |
Net Income to Common | -62.23 | -103.62 | -15.11 | -30.47 | 35.26 | 7.76 | Upgrade |
Net Income Growth | - | - | - | - | 354.55% | -64.59% | Upgrade |
Shares Outstanding (Basic) | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 | Upgrade |
Shares Outstanding (Diluted) | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 | Upgrade |
EPS (Basic) | -0.03 | -0.05 | -0.01 | -0.02 | 0.02 | 0.00 | Upgrade |
EPS (Diluted) | -0.03 | -0.05 | -0.01 | -0.02 | 0.02 | 0.00 | Upgrade |
EPS Growth | - | - | - | - | 354.65% | -64.59% | Upgrade |
Free Cash Flow | -43.67 | -54.96 | -47.39 | -32.75 | 6.5 | -43.72 | Upgrade |
Free Cash Flow Per Share | -0.02 | -0.03 | -0.02 | -0.02 | 0.00 | -0.02 | Upgrade |
Dividend Per Share | - | - | - | - | 0.003 | 0.003 | Upgrade |
Gross Margin | 55.52% | 57.21% | 59.62% | 56.31% | 62.73% | 58.54% | Upgrade |
Operating Margin | -0.75% | -13.95% | 0.12% | -5.75% | 9.46% | 2.46% | Upgrade |
Profit Margin | -13.49% | -29.30% | -4.50% | -9.07% | 7.23% | 1.89% | Upgrade |
Free Cash Flow Margin | -9.46% | -15.54% | -14.10% | -9.75% | 1.33% | -10.65% | Upgrade |
EBITDA | 26.23 | -23.02 | 21.4 | 4.61 | 72.04 | 37.51 | Upgrade |
EBITDA Margin | 5.68% | -6.51% | 6.37% | 1.37% | 14.77% | 9.13% | Upgrade |
D&A For EBITDA | 29.67 | 26.31 | 20.98 | 23.94 | 25.91 | 27.39 | Upgrade |
EBIT | -3.45 | -49.33 | 0.42 | -19.32 | 46.13 | 10.12 | Upgrade |
EBIT Margin | -0.75% | -13.95% | 0.12% | -5.75% | 9.46% | 2.46% | Upgrade |
Effective Tax Rate | - | - | - | - | 27.23% | 13.64% | Upgrade |
Advertising Expenses | - | 65.05 | 39.22 | 13.29 | 45.13 | 33.86 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.